Efficacy and safety of single agent pan-HER inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer (sSCC).
2017
9543Background: In recurrent/metastatic skin squamous cell cancer (sSCC) not
amenableto radiotherapy (RT) or surgery, chemotherapy (CT) has a palliative intent and limited clinical responses. We i...
Keywords:
-
Correction
-
Source
-
Cite
-
Save
0
References
2
Citations
NaN
KQI